MRNA Snapshot
Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.
Market Capitalization$70,576,685,000
Price to Sales5.97
Earnings per Share$16.6900
PE Ratio10.43
Most Recent Close$167.5200
52 Week High$497.49
52 Week Low$117.34
50-Day Moving Average$257.66
200-Day Moving Average$278.52
All data are from Alpha Vantage as of today. For more infomation on MRNA see Stock Dividend, Valuation, Price and Financial Data for Investors